Excerpt
Historical exclusion of women from basic, translational, and clinical research has led to an inadequate understanding of sex-based biological differences on health and disease burden and lack of therapies for women’s health. In October 2024, the National Academies Forum on Regenerative Medicine and Forum on Temporomandibular Disorders hosted a public workshop to consider gaps within regenerative medicine research related to conditions that are female-specific and/or are more common in or differently impact women; explore emerging and potential regenerative medicine therapies and technologies for these conditions; and examine women’s representation within the regenerative medicine workforce.
Copyright 2025 by the National Academy of Sciences. All rights reserved.
PubMed Disclaimer
Grants and funding
SPONSORS This workshop was partially supported by contracts between the National Academy of Sciences and Advanced Regenerative Manufacturing Institute; Akron Biotech; Alliance for Regenerative Medicine; American Academy of Oral Medicine; American Academy of Orofacial Pain; Academy of Orthopaedic Physical Therapy; American Medical Women’s Association; American Society of Gene & Cell Therapy; American Society of Temporomandibular Joint Surgeons; Burroughs Wellcome Fund (Grant No. 1325461); California Institute for Regenerative Medicine; Centre for Commercialization of Regenerative Medicine; Department of Veterans Affairs (Contract No. 36C24E21C0011); Food and Drug Administration: Center for Biologics Evaluation and Research (Contract No. 1R13FD008396-01 ) and Center for Devices and Radiological Health (Contract No. 75F40122D00002); International Society for Cellular Therapy; International Society for Stem Cell Research; Johnson & Johnson; National Institute of Standards and Technology; National Institutes of Health (Contract No. HHSN263201800029I; Task Order No. 75N98024F00002 and 75N98023F00008), including: National Center for Advancing Translational Sciences; National Eye Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Biomedical Imaging and Bioengineering; National Institute of Dental and Craniofacial Research; and National Institute of Diabetes and Digestive and Kidney Diseases; New York Stem Cell Foundation; Orofacial Therapeutics, Inc.; The TMJ Association, Ltd.; and United Therapeutics Corporation. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
